CME Group Inc. (CME) Position Boosted by LS Investment Advisors LLC
LS Investment Advisors LLC boosted its position in CME Group Inc. (NASDAQ:CME) by 1.4% during the second quarter, Holdings Channel reports. The firm owned 9,793 shares of the company’s stock after buying an additional 132 shares during the period. LS Investment Advisors LLC’s holdings in CME Group were worth $954,000 as of its most recent filing with the SEC.
A number of other institutional investors have also recently bought and sold shares of CME. Windward Capital Management Co. CA increased its position in shares of CME Group by 1.0% in the second quarter. Windward Capital Management Co. CA now owns 2,626 shares of the company’s stock valued at $256,000 after buying an additional 25 shares during the last quarter. Gofen & Glossberg LLC IL increased its position in shares of CME Group by 0.4% in the second quarter. Gofen & Glossberg LLC IL now owns 7,323 shares of the company’s stock valued at $713,000 after buying an additional 26 shares during the last quarter. Beacon Financial Group increased its position in shares of CME Group by 0.8% in the second quarter. Beacon Financial Group now owns 4,525 shares of the company’s stock valued at $435,000 after buying an additional 38 shares during the last quarter. iAB Financial Bank increased its position in shares of CME Group by 2.1% in the second quarter. iAB Financial Bank now owns 2,675 shares of the company’s stock valued at $261,000 after buying an additional 55 shares during the last quarter. Finally, Cullinan Associates Inc. increased its position in shares of CME Group by 0.3% in the second quarter. Cullinan Associates Inc. now owns 54,950 shares of the company’s stock valued at $5,352,000 after buying an additional 150 shares during the last quarter. Institutional investors and hedge funds own 80.29% of the company’s stock.
CME Group Inc. (NASDAQ:CME) traded down 0.17% on Tuesday, hitting $103.93. The stock had a trading volume of 1,334,388 shares. CME Group Inc. has a 12 month low of $81.87 and a 12 month high of $110.35. The company’s 50 day moving average is $106.65 and its 200-day moving average is $99.53. The stock has a market cap of $35.22 billion, a P/E ratio of 26.24 and a beta of 0.83.
CME Group (NASDAQ:CME) last issued its quarterly earnings data on Thursday, July 28th. The company reported $1.14 earnings per share for the quarter, topping analysts’ consensus estimates of $1.11 by $0.03. The firm earned $906 million during the quarter, compared to analysts’ expectations of $897.84 million. CME Group had a return on equity of 6.83% and a net margin of 38.22%. The firm’s quarterly revenue was up 10.5% on a year-over-year basis. During the same period in the prior year, the business posted $0.95 EPS. Analysts forecast that CME Group Inc. will post $4.43 EPS for the current year.
The firm also recently announced a quarterly dividend, which was paid on Monday, September 26th. Investors of record on Friday, September 9th were given a dividend of $0.60 per share. This represents a $2.40 annualized dividend and a yield of 2.31%. The ex-dividend date was Wednesday, September 7th. CME Group’s dividend payout ratio is currently 60.61%.
Several equities analysts have recently weighed in on the company. Deutsche Bank AG raised their price target on CME Group from $115.00 to $116.00 and gave the company a “buy” rating in a report on Wednesday, October 5th. JPMorgan Chase & Co. set a $116.00 price target on CME Group and gave the company a “buy” rating in a report on Monday, September 12th. Zacks Investment Research downgraded CME Group from a “buy” rating to a “hold” rating in a report on Wednesday, September 7th. Jefferies Group lifted their price objective on CME Group from $112.00 to $118.00 and gave the stock a “buy” rating in a report on Wednesday, August 31st. Finally, Keefe, Bruyette & Woods lifted their price objective on CME Group from $99.00 to $103.00 and gave the stock a “market perform” rating in a report on Friday, July 29th. Two investment analysts have rated the stock with a sell rating, six have assigned a hold rating and five have assigned a buy rating to the company’s stock. The stock has an average rating of “Hold” and a consensus target price of $103.27.
In other news, insider Kimberly S. Taylor sold 2,300 shares of the stock in a transaction dated Monday, August 1st. The stock was sold at an average price of $102.58, for a total value of $235,934.00. Following the transaction, the insider now directly owns 103,789 shares of the company’s stock, valued at $10,646,675.62. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director James E. Oliff sold 1,000 shares of the stock in a transaction dated Friday, July 15th. The shares were sold at an average price of $102.30, for a total value of $102,300.00. The disclosure for this sale can be found here. Corporate insiders own 0.61% of the company’s stock.
CME Group Company Profile
CME Group Inc is a provider of products across all major asset classes, based on interest rates, equity indexes, foreign exchange, energy, agricultural commodities and metals. The Company’s products include both exchange-traded and privately negotiated futures and options contracts and swaps. The Company connects buyers and sellers together through its CME Globex electronic trading platform across the globe and its open outcry trading facilities in Chicago and New York City.
Want to see what other hedge funds are holding CME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CME Group Inc. (NASDAQ:CME).
Receive News & Ratings for CME Group Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group Inc. and related companies with MarketBeat.com's FREE daily email newsletter.